RPID Stock Price, Chart, Stats & News
Rapid Micro Biosystems, Inc. (RPID) does not currently pay a dividend.
RPID chart
Fundamentals
Gross margin | 17.37% |
Operating margin | -141.11% |
Pretax margin | -140.19% |
Net margin | -140.30% |
Effective tax rate | -0.08% |
ROA | -62.96% |
ROE | -95.41% |
D/E | 0.72x |
Interest coverage ratio | -38.66x |
RPID valuation
P/E | – |
P/S | 2.98x |
P/B | 2.96x |
P/CF | -3.25x |
P/FCF | -3.22x |
P/OCF | -3.25x |
PEG | 0.35x |
EV multiple | -2.18x |
About
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications.
Similar securities
Based on sector and market capitalization
